Cargando…
Tetrahydrocurcumin Add‐On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury
Tetrahydrocurcumin (THC), a principal metabolite of curcumin, was tested in a rat model of type 2 diabetes mellitus. THC was administered via daily oral gavage with the lipid carrier polyenylphosphatidylcholine (PPC) as add‐on therapy to losartan (angiotensin receptor blocker) to examine effects on...
Autores principales: | Khazaeli, Mahyar, Nunes, Ane C. F., Zhao, Yitong, Khazaeli, Mahziar, Prudente, John, Vaziri, Nosratola D., Singh, Bhupinder, Lau, Wei Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041385/ https://www.ncbi.nlm.nih.gov/pubmed/36971089 http://dx.doi.org/10.1002/prp2.1079 |
Ejemplares similares
-
Dietary tetrahydrocurcumin reduces renal fibrosis and cardiac hypertrophy in 5/6 nephrectomized rats
por: Lau, Wei Ling, et al.
Publicado: (2018) -
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease
por: Aminzadeh, Mohammad A., et al.
Publicado: (2014) -
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease()
por: Aminzadeh, Mohammad A., et al.
Publicado: (2013) -
High Amylose Resistant Starch Diet Ameliorates Oxidative Stress, Inflammation, and Progression of Chronic Kidney Disease
por: Vaziri, Nosratola D., et al.
Publicado: (2014) -
The Clinical Utility and Impact of Next Generation Sequencing in Gynecologic Cancers
por: Maruthi, Vijaya Kadam, et al.
Publicado: (2022)